Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 169082, 14 pages
http://dx.doi.org/10.1155/2014/169082
Research Article

Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus

Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing 210008, China

Received 21 May 2014; Accepted 7 September 2014; Published 24 November 2014

Academic Editor: Enrico Maggi

Copyright © 2014 Linyu Geng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Minguell, C. Allers, and G. P. Lasala, “Mesenchymal stem cells and the treatment of conditions and diseases: the less glittering side of a conspicuous stem cell for basic research,” Stem Cells and Development, vol. 22, no. 2, pp. 193–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Zachos, A. Diggs, S. Weisbrode, J. Bartlett, and A. Bertone, “Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model,” Molecular Therapy, vol. 15, no. 8, pp. 1543–1550, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Puliafico, M. S. Penn, and K. H. Silver, “Stem cell therapy for heart disease,” Journal of General Internal Medicine, vol. 28, no. 10, pp. 1353–1363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. X.-Y. Zhu, A. Lerman, and L. O. Lerman, “Concise review: mesenchymal stem cell treatment for ischemic kidney disease,” Stem Cells, vol. 31, no. 9, pp. 1731–1736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. T. S. Stappenbeck and H. Miyoshi, “The role of stromal stem cells in tissue regeneration and wound repair,” Science, vol. 324, no. 5935, pp. 1666–1669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. F. E. Figueroa, F. Carrión, S. Villanueva, and M. Khoury, “Mesenchymal stem cell treatment for autoimmune diseases: a critical review,” Biological Research, vol. 45, no. 3, pp. 269–277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth, “MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines,” Blood, vol. 109, no. 9, pp. 4055–4063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Hemeda, M. Jakob, A.-K. Ludwig, B. Giebel, S. Lang, and S. Brandau, “Interferon-γ and tumor necrosis factor-α differentially affect cytokine expression and migration properties of mesenchymal stem cells,” Stem Cells and Development, vol. 19, no. 5, pp. 693–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Zhao, D. G. Phinney, D. Bonnet, M. Dominici, and M. Krampera, “Mesenchymal stem cell biodistribution, migration, and homing in vivo,” Stem Cells International, vol. 2014, Article ID 292109, 2 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Zelová and J. Hošek, “TNF-α signalling and inflammation: interactions between old acquaintances,” Inflammation Research, vol. 62, no. 7, pp. 641–651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Haasters, W. C. Prall, I. Westphal et al., “Overexpression of dnIKK in mesenchymal stem cells leads to increased migration and decreased invasion upon TNFα stimulation,” Biochemical and Biophysical Research Communications, vol. 436, no. 2, pp. 265–270, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Böcker, D. Docheva, W. C. Prall et al., “IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells,” Journal of Molecular Medicine, vol. 86, no. 10, pp. 1183–1192, 2008. View at Publisher · View at Google Scholar
  13. X. Fu, B. Han, S. Cai, Y. Lei, T. Sun, and Z. Sheng, “Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-α and its possible role in wound healing,” Wound Repair and Regeneration, vol. 17, no. 2, pp. 185–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Xu, C. Zhang, and D. T. Graves, “Abnormal cell responses and role of TNF-α in impaired diabetic wound healing,” BioMed Research International, vol. 2013, Article ID 754802, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Siqueira, J. Li, L. Chehab et al., “Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1),” Diabetologia, vol. 53, no. 2, pp. 378–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. L. Gurevitz, J. A. Snyder, E. K. Wessel, J. Frey, and B. A. Williamson, “Systemic lupus erythematosus: a review of the disease and treatment options,” Consultant Pharmacist, vol. 28, no. 2, pp. 110–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ikehara, “Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment (review),” International Journal of Molecular Medicine, vol. 1, no. 1, pp. 5–16, 1998. View at Google Scholar · View at Scopus
  18. L. Sun, D. Wang, J. Liang et al., “Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 62, no. 8, pp. 2467–2475, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Sun, K. Akiyama, H. Zhang et al., “Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans,” Stem Cells, vol. 27, no. 6, pp. 1421–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Wang, H. Zhang, J. Liang et al., “Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience,” Cell Transplantation, vol. 22, no. 12, pp. 2267–2277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Li, L. Liu, D. Meng et al., “Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus,” Stem Cells and Development, vol. 21, no. 13, pp. 2387–2394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Tang, X. Ma, H. Zhang et al., “Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus,” Clinical and Developmental Immunology, vol. 2012, Article ID 826182, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, article 1725, 1997. View at Google Scholar · View at Scopus
  24. G. Hawker, S. Gabriel, C. Bombardier, C. Goldsmith, D. Caron, and D. Gladman, “A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus,” The Journal of Rheumatology, vol. 20, no. 4, pp. 657–660, 1993. View at Google Scholar · View at Scopus
  25. P. L. Podolin, J. F. Callahan, B. J. Bolognese et al., “Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IκB kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation,” Journal of Pharmacology and Experimental Therapeutics, vol. 312, no. 1, pp. 373–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Zhang, Y. Wang, Z. Ye, H. Xie, L. Zhou, and S. Zheng, “Mechanism of TNF-α-induced migration and hepatocyte growth factor production in human mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 111, no. 2, pp. 469–475, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Wei, X. Yang, Z.-P. Han, F.-F. Qu, L. Shao, and Y.-F. Shi, “Mesenchymal stem cells: a new trend for cell therapy,” Acta Pharmacologica Sinica, vol. 34, no. 6, pp. 747–754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Xiao, S.-K. Wang, H. Tian et al., “TNF-α increases bone marrow mesenchymal stem cell migration to ischemic tissues,” Cell Biochemistry and Biophysics, vol. 62, no. 3, pp. 409–414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Postal and S. Appenzeller, “The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus,” Cytokine, vol. 56, no. 3, pp. 537–343, 2011. View at Publisher · View at Google Scholar
  30. J. P. Lopes, A. Fiarresga, P. S. Cunha, J. Feliciano, and R. C. Ferreira, “Mesenchymal stem cell therapy in heart disease,” Revista Portuguesa de Cardiologia, vol. 32, no. 1, pp. 43–47, 2013. View at Publisher · View at Google Scholar
  31. H. Zhuang, S. Han, Y. Xu et al., “Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus,” Arthritis & Rheumatology, vol. 66, no. 1, pp. 140–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. L. Kelly, M. Wang, P. R. Crisostomo et al., “TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia,” Shock, vol. 33, no. 6, pp. 602–607, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Karin, Y. Yamamoto, and Q. M. Wang, “The IKK NF-κB system: a treasure trove for drug development,” Nature Reviews Drug Discovery, vol. 3, no. 1, pp. 17–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Ferrand, P. Lehours, A. Schmid-Alliana, F. Mégraud, and C. Varon, “Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-κB-dependent pathway,” PLoS ONE, vol. 6, no. 12, Article ID e29007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Hayden and S. Ghosh, “NF-κB in immunobiology,” Cell Research, vol. 21, no. 2, pp. 223–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Devin, Y. Lin, S. Yamaoka, Z. Li, M. Karin, and Z.-G. Liu, “The α and β subunits of IκB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF,” Molecular and Cellular Biology, vol. 21, no. 12, pp. 3986–3994, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Murakami, S. Fukuchi, K. Takeuchi, T. Hori, S. Shibamoto, and F. Ito, “Antagonistic regulation of cell migration by epidermal growth factor and glucocorticoid in human gastric carcinoma cells,” Journal of Cellular Physiology, vol. 176, no. 1, pp. 127–137, 1998. View at Google Scholar
  38. R. A. Blaheta, K. Leckel, B. Wittig et al., “Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells,” Transplantation Proceedings, vol. 31, no. 1-2, pp. 1250–1252, 1999. View at Publisher · View at Google Scholar
  39. J. R. Waller, N. R. Brook, G. R. Bicknell, G. J. Murphy, and M. L. Nicholson, “Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration,” Transplantation Proceedings, vol. 37, no. 1, pp. 164–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-P. Lévesque, J. Hendy, Y. Takamatsu, P. J. Simmons, and L. J. Bendall, “Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by gcsf or cyclophosphamide,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 187–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Secchiero, E. Melloni, F. Corallini et al., “Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells,” Stem Cells, vol. 26, no. 11, pp. 2955–2963, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Carrero, I. Cerrada, E. Lledó et al., “IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB,” Stem Cell Reviews and Reports, vol. 8, no. 3, pp. 905–916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Tondreau, N. Meuleman, B. Stamatopoulos et al., “In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues,” Cytotherapy, vol. 11, no. 5, pp. 559–569, 2009. View at Publisher · View at Google Scholar · View at Scopus